Aprotinin in orthotopic liver transplantation: Evidence for a prohemostatic, but not a prothrombotic, effect
I. Quintus Molenaar, Cristina Legnani, Theo H.N. Groenland, Gualtiero Palareti, Bruno Begliomini, Onno T. Terpstra, Robert J. Porte – 30 December 2003 – Aprotinin reduces blood transfusion requirements in orthotopic liver transplantation (OLT). Concern has been voiced about the potential risk for thrombotic complications when aprotinin is used. The aim of this study is to evaluate the effects of aprotinin on the two components of the hemostatic system (coagulation and fibrinolysis) in patients undergoing OLT.